LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
16347-7 | Alpha chlordane | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Alpha chlordane [Mass/volume] in Blood | A-Chlordane Bld-mCnc | null | ACTIVE | 1.0l | 2.73 |
16348-5 | Alpha hydroxyalprazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method | A-OH Alpraz Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16349-3 | Aluminum | MCnc | Pt | Body fld | Qn | null | DRUG/TOX | 1 | Aluminum [Mass/volume] in Body fluid | Aluminum Fld-mCnc | null | ACTIVE | 1.0l | 2.42 |
16350-1 | Amantadine | Titr | Pt | Isolate+Ser | Qn | SBT | ABXBACT | 1 | Amantadine [Susceptibility] by Serum bactericidal titer | Amantadine Titr SBT | null | ACTIVE | 1.0l | 2.32 |
16351-9 | aMILoride | ACnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | aMILoride [Units/volume] in Serum or Plasma | aMILoride SerPl-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
1635-2 | Somatotropin^pre 1 g/kg glucose PO | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO | GH pre 1 g/kg Glc PO SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
16352-7 | aMILoride | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | aMILoride [Units/volume] in Urine | aMILoride Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16353-5 | Amino beta guanidinopropionate | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Amino beta guanidinopropionate [Presence] in Urine | AB-Gp Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16354-3 | Amino beta guanidinopropionate | MCnc | Pt | Urine | Qn | null | CHEM | 1 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Urine | Deprecated AB-Gp Ur-mCnc | null | DEPRECATED | 1.0l | 2.36 |
16355-0 | Amino beta guanidinopropionate | PrThr | Pt | Plas | Ord | null | CHEM | 1 | Amino beta guanidinopropionate [Presence] in Plasma | AB-Gp Plas Ql | null | ACTIVE | 1.0l | 2.56 |
16356-8 | Amino beta guanidinopropionate | MCnc | Pt | Plas | Qn | null | CHEM | 1 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Plasma | Deprecated AB-Gp Plas-mCnc | null | DEPRECATED | 1.0l | 2.36 |
16357-6 | Amino beta guanidinopropionate | MCnc | Pt | CSF | Qn | null | CHEM | 1 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid | Deprecated AB-Gp CSF-mCnc | null | DEPRECATED | 1.0l | 2.36 |
16358-4 | Amino beta guanidinopropionate | MCnc | Pt | Amnio fld | Qn | null | CHEM | 1 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid | Deprecated AB-Gp Amn-mCnc | null | DEPRECATED | 1.0l | 2.36 |
16359-2 | Amiodarone+Desethylamiodarone | MCnc | Pt | Ser | Qn | null | DRUG/TOX | 1 | Deprecated Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma | Deprecated Amiodarone+Deseth Ser-mCnc | null | DEPRECATED | 1.0l | 2.36 |
163-6 | Cephalothin | Titr | Pt | Isolate+Ser | Qn | SBT | ABXBACT | 1 | Cephalothin [Susceptibility] by Serum bactericidal titer | Cephalothin Titr SBT | null | ACTIVE | 1.0 | 2.32 |
1636-0 | Somatotropin^pre 250 ug L-Dopa TID 2day PO | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO | GH pre 250 ug L-D TID 2D PO SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16360-0 | Amitriptyline^peak | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Amitriptyline [Mass/volume] in Serum or Plasma --peak | Amitrip Peak SerPl-mCnc | null | ACTIVE | 1.0l | 2.40 |
16361-8 | Amitriptyline^trough | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Amitriptyline [Mass/volume] in Serum or Plasma --trough | Amitrip Trough SerPl-mCnc | null | ACTIVE | 1.0l | 2.40 |
16362-6 | Ammonia | SCnc | Pt | Plas | Qn | null | CHEM | 1 | Ammonia [Moles/volume] in Plasma | Ammonia Plas-sCnc | null | ACTIVE | 1.0l | 2.73 |
16363-4 | Ammonia | SCnt | Pt | Tiss | Qn | null | CHEM | 1 | Ammonia [Moles/mass] in Tissue | Ammonia Tiss-sCnt | null | ACTIVE | 1.0l | 2.42 |
16364-2 | Amobarbital | MCnc | Pt | Gast fld | Qn | null | DRUG/TOX | 1 | Amobarbital [Mass/volume] in Gastric fluid | Amobarbital Gast-mCnc | null | ACTIVE | 1.0l | 2.42 |
16365-9 | Amoxicillin+Clavulanate | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Deprecated Amoxicillin+Clavulanate [Mass/volume] in Serum or Plasma | Deprecated Amoxicillin+Clav SerPl-mCnc | null | DEPRECATED | 1.0l | 2.65 |
16366-7 | Diethylpropion | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Diethylpropion [Mass/volume] in Serum or Plasma | Diethylpropion SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16367-5 | Amphetamine/Methamphetamine | MCrto | Pt | Urine | Ord | null | DRUG/TOX | 1 | Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative | Deprecated Amphet/Methamphet Ur | null | DEPRECATED | 1.0l | 2.40 |
16369-1 | Amphetamines | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Amphetamines [Presence] in Urine by Confirmatory method | Amphetamines Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16370-9 | Amphotericin B | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Amphotericin B [Mass/volume] in Urine | Amphotericin B Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
16373-3 | Amyl ether | PrThr | Pt | Bld | Ord | null | DRUG/TOX | 1 | Amyl ether [Presence] in Blood | Amyl ether Bld Ql | null | ACTIVE | 1.0l | 2.56 |
16374-1 | Amyl nitrite | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Amyl nitrite [Mass/volume] in Serum or Plasma | Amyl nitrite SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
1637-8 | Somatotropin^pre dose insulin IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV | GH pre Ins IV SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16378-2 | Androstenedione^2nd specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge | Androst sp2 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16379-0 | Androstenedione^3rd specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge | Androst sp3 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16380-8 | Androstenedione^4th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge | Androst sp4 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16381-6 | Androstenedione^5th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge | Androst sp5 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16382-4 | Androstenedione^6th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge | Androst sp6 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16383-2 | Androstenedione^7th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Androst sp7 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16384-0 | Androstenedione^8th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | Androst sp8 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16385-7 | Androstenedione^9th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Androst sp9 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
1638-6 | Testosterone^96H post 5000 U HCG IM | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM | Testost 96h p 5000 U HCG IM SerPl-mCnc | null | ACTIVE | 1.0 | 2.34 |
16386-5 | Rifabutin | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) | Deprecated Rifabutin Islt MIC | null | DEPRECATED | 1.0l | 2.36 |
16387-3 | Rifabutin+Ethambutol | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Rifabutin+Ethambutol Islt MIC | null | ACTIVE | 1.0l | 2.19 |
16388-1 | Anticonvulsants | Prid | Pt | Urine | Nom | null | DRUG/TOX | 1 | Anticonvulsants [Identifier] in Urine | Anticonvulsants Ur | null | ACTIVE | 1.0l | 2.73 |
16389-9 | Antidepressants | Prid | Pt | Ser/Plas | Nom | null | DRUG/TOX | 1 | Antidepressants [Identifier] in Serum or Plasma | Antidepressants SerPl | null | ACTIVE | 1.0l | 2.73 |
16390-7 | Antidiuretics | Prid | Pt | Urine | Nom | null | DRUG/TOX | 1 | Antidiuretics [Identifier] in Urine | Antidiuretics Ur | null | ACTIVE | 1.0l | 2.19 |
16391-5 | Antimony | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Antimony [Presence] in Urine | Antimony Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16392-3 | Nuclear Ab | PrThr | Pt | Ser | Ord | Rodent substrate | SERO | 1 | Nuclear Ab [Presence] in Serum by Rodent substrate | ANA Ser Ql Rodent subst | null | ACTIVE | 1.0l | 2.73 |
16393-1 | Nuclear Ab | ACnc | Pt | Ser | Qn | Rodent substrate | SERO | 1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate | ANA Ser Rodent subst-aCnc | null | ACTIVE | 1.0l | 2.69 |
1639-4 | Testosterone^pre 5000 U HCG IM | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM | Testost pre 5000 U CG IM SerPl-mCnc | null | ACTIVE | 1.0 | 2.34 |
16394-9 | Nuclear Ab | PrThr | Pt | Body fld | Ord | IF | SERO | 1 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence | ANA Fld Ql IF | null | ACTIVE | 1.0l | 2.56 |
16395-6 | Antipsychotics | Prid | Pt | Urine | Nom | null | DRUG/TOX | 1 | Antipsychotics [Identifier] in Urine | Antipsychotics Ur | null | ACTIVE | 1.0l | 2.73 |
16400-4 | Appearance | Aper | Pt | Semin plas | Nom | null | SPEC | 1 | Appearance of Seminal plasma | Appearance Semin plas | null | ACTIVE | 1.0l | 2.73 |
16401-2 | Arginine | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Arginine [Presence] in Urine | Arginine Ur Ql | null | ACTIVE | 1.0l | 2.56 |
1640-2 | Thyrotropin^30M post dose TRH IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV | TSH 30M p TRH IV SerPl-mCnc | null | DISCOURAGED | 1.0 | 2.73 |
16402-0 | Aromatic solvents | Prid | Pt | Bld | Nom | null | DRUG/TOX | 1 | Aromatic solvents [Identifier] in Blood | Arom Solvents Bld | null | ACTIVE | 1.0l | 2.07 |
16403-8 | Arsenic | PrThr | Pt | Ser/Plas | Ord | null | DRUG/TOX | 1 | Arsenic [Presence] in Serum or Plasma | Arsenic SerPl Ql | null | ACTIVE | 1.0l | 2.56 |
16404-6 | Arsenic | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Arsenic [Presence] in Urine | Arsenic Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16405-3 | Arylamidase | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Arylamidase [Presence] in Urine | Arylamidase Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16406-1 | Arylamidase | CCnc | Pt | Urine | Qn | null | CHEM | 1 | Arylamidase [Enzymatic activity/volume] in Urine | Arylamidase Ur-cCnc | null | ACTIVE | 1.0l | 2.68 |
16407-9 | Asbestos identified | Prid | Pt | Sputum | Nom | Microscopy.light | DRUG/TOX | 1 | Asbestos identified in Sputum by Light microscopy | Asbestos Spt Micro | null | ACTIVE | 1.0l | 2.19 |
16408-7 | Ascorbate | MCnc | Pt | Urine | Qn | null | CHEM | 1 | Ascorbate [Mass/volume] in Urine | Vit C Ur-mCnc | null | ACTIVE | 1.0l | 2.73 |
16409-5 | Ascorbate^post dose | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Ascorbate [Mass/volume] in Serum or Plasma --post dose | Vit C p dose SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
1641-0 | Thyrotropin^1H post dose TRH IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Thyrotropin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV | TSH 1h p TRH IV SerPl-mCnc | null | DISCOURAGED | 1.0 | 2.73 |
16410-3 | Asparagine | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Asparagine [Presence] in Urine | Asparagine Ur Ql | null | ACTIVE | 1.0l | 2.73 |
16411-1 | Aspartate | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Aspartate [Presence] in Urine | Aspartate Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16412-9 | Aspartate aminotransferase | CCnc | Pt | RBC | Qn | null | CHEM | 1 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells | AST RBC-cCnc | null | ACTIVE | 1.0l | 2.68 |
16414-5 | Aspergillus amstelodami Ab | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Aspergillus amstelodami Ab [Units/volume] in Serum | A amstelodami Ab Qn | null | ACTIVE | 1.0l | 2.69 |
16415-2 | Aspergillus flavus Ab | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid | A flavus Ab CSF Ql | null | ACTIVE | 1.0l | 2.73 |
16416-0 | Aspergillus terreus Ab | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Aspergillus terreus Ab [Units/volume] in Serum | A terreus Ab Qn | null | ACTIVE | 1.0l | 2.69 |
16417-8 | Aspergillus versicolor Ab | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Aspergillus versicolor Ab [Units/volume] in Serum | A versicolor Ab Qn | null | ACTIVE | 1.0l | 2.69 |
16418-6 | Azatadine | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Azatadine [Presence] in Urine | Azatadine Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16419-4 | azaTHIOprine | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | azaTHIOprine [Mass/volume] in Serum or Plasma | azaTHIOprine SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16420-2 | Azithromycin | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Azithromycin [Mass/volume] in Serum or Plasma | Azithromycin SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16421-0 | Azithromycin+Ethambutol | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Azithro+Ethambut Islt MIC | null | ACTIVE | 1.0l | 2.19 |
16422-8 | Azlocillin | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Azlocillin [Mass/volume] in Urine | Azlocillin Ur-mCnc | null | ACTIVE | 1.0l | 2.34 |
16423-6 | Aztreonam | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Aztreonam [Mass/volume] in Urine | Aztreonam Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
16424-4 | Salicylazosulfapyridine | MCnc | Pt | Ser | Qn | null | DRUG/TOX | 1 | Deprecated sulfaSALAzine [Mass/volume] in Serum or Plasma | Deprecated Salicylazosulfapyridine Ser | null | DEPRECATED | 1.0l | 2.36 |
16425-1 | Babesia sp Ab.IgM | ACnc | Pt | Ser | Qn | IF | MICRO | 1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence | Babesia IgM Ser IF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16426-9 | Babesia sp Ab.IgM | Titr | Pt | Ser | Qn | null | MICRO | 1 | Babesia sp IgM Ab [Titer] in Serum | Babesia IgM Titr Ser | null | ACTIVE | 1.0l | 2.70 |
16427-7 | Babesia microti Ab | Titr | Pt | Ser | Qn | null | MICRO | 1 | Babesia microti Ab [Titer] in Serum | B microti Ab Titr Ser | null | ACTIVE | 1.0l | 2.70 |
1642-8 | Thyrotropin^baseline | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Thyrotropin [Mass/volume] in Serum or Plasma --baseline | TSH BS SerPl-mCnc | null | DISCOURAGED | 1.0 | 2.73 |
16428-5 | Bacitracin | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Bacitracin [Mass/volume] in Serum or Plasma | Bacitracin SerPl-mCnc | null | ACTIVE | 1.0l | 2.42 |
16429-3 | Barbiturates | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Barbiturates [Presence] in Urine by Confirmatory method | Barbiturates Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16430-1 | Barbiturates | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Barbiturates [Units/volume] in Urine | Barbiturates Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16431-9 | Barium | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Barium [Presence] in Urine | Barium Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16432-7 | Barium | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Barium [Mass/volume] in Blood | Barium Bld-mCnc | null | ACTIVE | 1.0l | 2.73 |
16433-5 | Basement membrane Ab | PrThr | Pt | Ser | Ord | null | SERO | 1 | Basement membrane Ab [Presence] in Serum | BM Ab Ser Ql | null | ACTIVE | 1.0l | 2.73 |
16434-3 | Basement membrane Ab | ACnc | Pt | Ser | Qn | IF | SERO | 1 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence | BM Ab Ser IF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16435-0 | Bean white Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Deprecated White Bean IgE Ab [Units/volume] in Serum | Deprecated White Bean IgE Qn | null | DEPRECATED | 1.0l | 2.69 |
1643-6 | Thyrotropin^pre dose TRH IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV | TSH pre TRH IV SerPl-mCnc | null | DISCOURAGED | 1.0 | 2.42 |
16436-8 | Bean wax Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Deprecated Bean string IgE Ab [Units/volume] in Serum | Deprecated Wax Bean IgE Qn | null | DEPRECATED | 1.0l | 2.69 |
16437-6 | Bendroflumethiazide | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Bendroflumethiazide [Units/volume] in Urine | Bendroflumethiaz Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16438-4 | Benzaldehyde | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Benzaldehyde [Presence] in Urine | Benzaldehyde Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16439-2 | Benzene | PrThr | Pt | Bld | Ord | null | DRUG/TOX | 1 | Benzene [Presence] in Blood | Benzene Bld Ql | null | ACTIVE | 1.0l | 2.56 |
164-4 | Cephapirin | Susc | Pt | Isolate | Qn | MLC | ABXBACT | 1 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) | Cephapirin Islt MLC | null | ACTIVE | 1.0 | 2.19 |
16440-0 | Benzene ring Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Benzene ring IgE Ab [Units/volume] in Serum | Benzene ring IgE Qn | null | ACTIVE | 1.0l | 2.42 |
16441-8 | Benzene ring Ab.IgG | ACnc | Pt | Ser | Qn | null | SERO | 1 | Benzene ring IgG Ab [Units/volume] in Serum | Benzene ring IgG Ser-aCnc | null | ACTIVE | 1.0l | 2.69 |
16442-6 | Benzene ring Ab.IgM | ACnc | Pt | Ser | Qn | null | SERO | 1 | Benzene ring IgM Ab [Units/volume] in Serum | Benzene ring IgM Ser-aCnc | null | ACTIVE | 1.0l | 2.69 |
16443-4 | Benzonatate | MCnc | Pt | Ser | Qn | null | DRUG/TOX | 1 | Benzonatate [Mass/volume] in Serum | Benzonatate Ser-mCnc | null | ACTIVE | 1.0l | 2.42 |
1644-4 | Triglyceride^post 12H CFst | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting | Trigl p 12h fast SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
16444-2 | Benzophenone | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Benzophenone [Mass/volume] in Serum or Plasma | Benzophenone SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16446-7 | Benzoylecgonine | PrThr | Pt | Ser/Plas | Ord | Confirm | DRUG/TOX | 1 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method | BZE SerPl Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.